2026 NPPES data Urology Physician NPI 1427052992 MD
Verify on CMS →

STEPHEN HARDEMAN, MD

Urology Physician in AUSTIN, Texas. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
3K
Medicare Part D claims · 669 beneficiaries · Urology Physician avg: 1K
Generic prescribing
94%
generic claims · 6% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
89.8/100
▲ 7 pts above national avg 83.1 · [object Object]
Industry payments
$1.2K
49 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: STEPHEN HARDEMAN, MD is a Urology Physician ([object Object]) practicing in AUSTIN, Texas with a Medicare Part D prescribing footprint of 3K claims across 669 beneficiaries — 6% brand-name prescribing . Their CMS MIPS Final Score of 89.8/100 (national average: 83.1) reflects performance across Quality, Cost, Interoperability, and Improvement Activities . Industry payments of $1.2K across 49 transactions are disclosed under CMS Open Payments (Sunshine Act).

What the federal data shows

STEPHEN HARDEMAN, MD reported a CMS MIPS final score of 89.8/100 — above the 83.1 national average — and filed 2,718 Medicare Part D claims in 2023.

89.8/100
MIPS score · +7 vs avg
3K
Part D claims, 2023
94%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

STEPHEN HARDEMAN, MD's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

90 Top 42% higher than 58% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). This entry sits in this band. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

STEPHEN HARDEMAN, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

STEPHEN HARDEMAN, MD at a glance

High performer (top quartile)

NPI registry status

Active

Issued 06/13/2005

NPI 1427052992

Primary specialty

Urology Physician

Mid-sized

13,350 US NPIs in this specialty

Medicare Part D claims

2,718 112% vs specialty avg

2023 prescription claims

Specialty avg: 1,280

MIPS final score

89.8/100 6.700000000000003% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in Texas

How Urology Physician compares to other specialties among Texas providers

Texas providers

Urology Physician share within Texas

1. Urology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Urology Physician share within Texas

Medicare quality performance — MIPS

STEPHEN HARDEMAN, MD's 2023 MIPS final score plotted against the Urology Physician national average

High performer (top quartile)
MIPS Final Score
89.8/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Urology Physician) — 89.8/100 vs national avg 83.1

0%100%National avg83%89.8%
MIPS final score (Urology Physician) — 89.8/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

STEPHEN HARDEMAN, MD is a Urology Physician provider practicing in AUSTIN, Texas, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: MD. NPI: 1427052992. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

STEPHEN HARDEMAN, MD appears in the CMS NPPES registry as a Urology Physician provider holding MD credentials at 11410 JOLLYVILLE RD STE 1101, AUSTIN, TX, 78759, with a listed phone of (512) 231-1444. NPI 1427052992 was issued on 06/13/2005. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what HARDEMAN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 2,718 prescription claims written by this provider, covering 669 Medicare beneficiaries and totaling roughly $339K in drug spend, split 6% brand-name and 94% generic by claim count, with an opioid prescribing rate of 1.7%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 89.8/100 for the 2023 performance year, compared with the national average of 83.1.

Urology Physician is a mid-sized specialty nationwide, with 13,350 enrolled providers across 54 states and an average of 1,280 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

11410 JOLLYVILLE RD STE 1101
AUSTIN, TX 78759

Provider Details

NPI 1427052992
Specialty Urology Physician
Credentials MD
Gender Male
NPI Issued 06/13/2005

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

89.8
Final Score
Avg: 83.1
88
Promoting Interoperability

Reporting: Group practice

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for STEPHEN HARDEMAN, MD. Source: openpaymentsdata.cms.gov.

Total received

$1.2K

Largest payer

ABBVIE INC.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Texas TMB 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 — they are NOT specific to STEPHEN HARDEMAN, MD. To verify STEPHEN HARDEMAN, MD's current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

344
Total board actions, Texas 2023
Across 334 cases
4.47
Actions per 1,000 licensees
Texas statewide rate
probation
Most common action type
94 cases

TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Generic-heavy

STEPHEN HARDEMAN, MD — brand share 6.0%
Specialty average (est.)

6% brand-name claims vs 94% generic, on 2,718 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

2,718
Total Claims
$339K
Total Drug Cost
669
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
6,683
Total Day Supply
195,374
Brand vs Generic
6% brand / 94% generic
Brand Drug Cost
$159K
Generic Drug Cost
$179K
Opioid Claims
45 (1.7% rate)
Antibiotic Claims
234

Patient Demographics

Average Patient Age
76.4 years
Avg HCC Risk Score
1.22
Gender Split
4% female / 96% male
Age Distribution
<65: 13, 65-74: 271, 75-84: 276, 85+: 109

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Tamsulosin Hcl
785
Dutasteride
413
Finasteride
259
Alfuzosin Hcl Er
Alfuzosin Hcl
194
Testosterone
103
Amoxicillin-Clavulanate Potass
Amoxicillin/Potassium Clav
95
Myrbetriq
Mirabegron
94
Testosterone Cypionate
87
Anastrozole
69
Terazosin Hcl
64

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Urology Physician Overview

How STEPHEN HARDEMAN, MD fits within the Urology Physician landscape nationally.

13,350
Urology Physician Providers in US
54
States with Urology Physician
1,280
Avg Claims per Provider

STEPHEN HARDEMAN, MD's 2,718 claims are above the specialty average of 1,280.

Nearby Urology Physician Providers in Texas

Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as HARDEMAN.

Compare Urology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is STEPHEN HARDEMAN, MD's specialty?
STEPHEN HARDEMAN, MD specializes in Urology Physician and practices in AUSTIN, Texas. Credentials: MD.
How much does STEPHEN HARDEMAN, MD prescribe under Medicare Part D?
In 2023, STEPHEN HARDEMAN, MD wrote 2,718 Medicare Part D claims totaling $339K in drug costs for 669 beneficiaries.
What is STEPHEN HARDEMAN, MD's Medicare quality score?
STEPHEN HARDEMAN, MD has a CMS MIPS Final Score of 89.8/100. The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is STEPHEN HARDEMAN, MD located?
STEPHEN HARDEMAN, MD is located at 11410 JOLLYVILLE RD STE 1101, AUSTIN, TX, 78759. Phone: (512) 231-1444.
What is STEPHEN HARDEMAN, MD's NPI number?
STEPHEN HARDEMAN, MD's National Provider Identifier (NPI) is 1427052992, issued on 06/13/2005.
Does STEPHEN HARDEMAN, MD prescribe more brand-name or generic drugs?
STEPHEN HARDEMAN, MD's prescribing is 6% brand-name and 94% generic drugs by claim count, with $159K in brand drug costs.
Does STEPHEN HARDEMAN, MD prescribe opioids?
Yes, STEPHEN HARDEMAN, MD had 45 opioid claims in 2023 with an opioid prescribing rate of 1.7%.
How many Urology Physician providers are there in the US?
There are 13,350 Urology Physician providers across 54 states in the US. The average Urology Physician provider writes 1,280 Medicare Part D claims per year.
What drugs does STEPHEN HARDEMAN, MD prescribe most often?
Based on 2023 Medicare Part D data, STEPHEN HARDEMAN, MD's most frequently prescribed drugs include Tamsulosin Hcl, Dutasteride, Finasteride. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does STEPHEN HARDEMAN, MD accept Medicare?
STEPHEN HARDEMAN, MD appears in CMS Medicare data with 2,718 Part D claims and 669 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify STEPHEN HARDEMAN, MD's credentials?
STEPHEN HARDEMAN, MD's NPI is 1427052992 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology